...
首页> 外文期刊>Journal of Surgical Oncology >Histopathological predictors for local recurrence in patients with T3 and T4 rectal cancers without preoperative chemoradiotherapy
【24h】

Histopathological predictors for local recurrence in patients with T3 and T4 rectal cancers without preoperative chemoradiotherapy

机译:未经术前放化疗的T3和T4直肠癌患者局部复发的组织病理学预测

获取原文
获取原文并翻译 | 示例
           

摘要

Background and Objectives: Identification of suitable predictors of local recurrence (LR) in patients with rectal cancer would be of clinical benefit. The aim of this study was to identify histopathological factors that could predict LR.Methods: Atotal of 796 stage II/III patients with pT3 and pT4 rectal cancer who did not undergo preoperative chemoradiation were enrolled. LR was defined as intra-pelvic recurrence only. Histopathological factors related to LR were investigated.Results: LR was found in 25 patients (6.1%) with stage II and 54 patients (13.9%) with stage IIIB/IIIC. In patients with stage II, distance of mesorectal extension (DME) >4mm (P=0.011) and positive venous invasion (P=0.035) were independent factors that predicted LR. In patients with stage IIIB/IIIC, circumferential resection margin (CRM) ≤1mm (P=0.003) and positive lymphatic invasion (P=0.006) were independent factors. The cumulative 5-year LR rate was higher (11.9%) in patients with a combination of DME>4mm and/or positive venous invasion for stage II (P<0.001), and was also higher in patients with a combination of CRM≤1mm and/or positive lymphatic invasion for stage IIIB and IIIC (22.2%; P<0.002, and 34.3%; P<0.006, respectively).Conclusions: Important histopathological predictors for LR in patients with pT3 and pT4 rectal cancer were different at each stage.
机译:背景与目的:确定直肠癌患者局部复发(LR)的合适预测指标将具有临床益处。本研究的目的是确定可预测LR的组织病理学因素。方法:招募了总共796例未进行术前化学放射治疗的II / III期pT3和pT4直肠癌患者。 LR仅定义为盆腔内复发。结果:在25例II期患者(6.1%)和54例IIIB / IIIC患者(13.9%)中发现了LR。在II期患者中,直肠系膜延伸距离(DME)> 4mm(P = 0.011)和静脉浸润阳性(P = 0.035)是预测LR的独立因素。在IIIB / IIIC期患者中,周缘切缘(CRM)≤1mm(P = 0.003)和淋巴管浸润阳性(P = 0.006)是独立因素。 DME> 4mm合并/或II期静脉侵袭阳性的患者的5年累积LR率较高(11.9%),而CRM≤1mm的合并患者的5年累积LR率较高。和/或IIIB和IIIC期淋巴结转移阳性(分别为22.2%; P <0.002和34.3%; P <0.006)。结论:pT3和pT4直肠癌患者LR的重要组织病理学预测指标在每个阶段均不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号